CompletedNot Applicable

Evaluation of Using Different Screwed Abutment Height

Spain30 participantsStarted 2017-07-01

Plain-language summary

A prospective randomized controlled clinical trial will be conducted. Study groups will be assigned as described above. The patients will be randomly divided into two groups in order to study the influence of prosthetic screw abutment in marginal bone loss (MBL) around Bone Level Tapered implants (BLT® Roxolid® SLActive® guided implants, Straumann Dental Implant System, Institut Straumann AG, Basel, Switzerland).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Signed informed consent
✓. Overall, healthy subjects
✓. Females and males of at least eighteen-years
✓. Requiring a minimum of two implants (molar and/or premolar teeth)
✓. Adequate oral hygiene (less than 15% FMPS)
✓. Able to follow instructions and attend a regular compliance
✓. Enough bone to place a standard implant of 4.1 mm diameter.

Exclusion criteria

✕. Acute local infection
✕. Occlusal overload with parafunctional activity (assessed clinically)
✕. Large occlusal discrepancies
✕. Untreated periodontal disease assessed by Socransky et al. parameters (≥2mm clinical attachment loss in two consecutive visits within 1 year)
✕. Smokers (more than 10 cigarettes/day)
✕. Drug and/or alcoholic dependencies
✕. Medical conditions contraindicating implant surgery
✕. History of head and/or neck radiation

What they're measuring

Marginal Bone Loss

Timeframe: After implant loading (baseline)and once every year to 24 months follow-up

Trial details

NCT IDNCT06017115

SponsorUniversitat Internacional de Catalunya

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-30

Results submitted2025-03-05

View on ClinicalTrials.gov More Bone Loss trials